FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Achives
 
Powered by Google
 

Direct-to-Consumer (DTC) Television User Fee Program Documents

1/15/2008: The Food and Drug Administration (FDA) is issuing this notice to inform companies that the Direct-to-Consumer (DTC) television advertisement user fee program will not commence because the necessary user fees for the program were not "provided in advance in appropriations Acts" as required by the Food and Drug Administration Amendments Act of 2007 (FDAAA). Federal Register notice [HTML] [PDF]

If you have questions about the DTC user fee program or about submitting DTC TV ads for advisory review, please contact either Mr. Wayne Amchin or Mr. Paul Loebach at (301) 796-1200.

Proposed DTC TV Advertisements Voluntarily Submitted for DDMAC Advisory Review

Since the DTC User Fee Program will not be implemented, all direct-to-consumer (DTC) television advertisements voluntarily submitted for DDMAC advisory review should be sent directly to FDA’s central document room to the attention of DDMAC’s Project Management Team. Please send these submissions to:

Wayne Amchin
Project Manager
Division of Drug Marketing,
Advertising and Communications
Food and Drug Administration
Center for Drug Evaluation and Research
5901-B Ammendale Road
Beltsville, MD 20705-1266

Attention:  DTC TV Ad for Advisory Review

DDMAC strongly encourages companies to note on the exterior package that the submission is a proposed DTC TV ad for DDMAC advisory review. Companies with questions about submission of proposed DTC TV advertisements should contact Wayne Amchin or Paul Loebach at 301-796-1200 or by email at dtcp@fda.hhs.gov.

Companies planning to send more than one proposed DTC television advertisement to DDMAC for advisory review should not consolidate them into one submission. Each proposed DTC television advertisement for advisory review should be submitted separately (not bundled together), and each submission should be complete and reviewable as a stand-alone submission.  

What Constitutes a Complete and Reviewable DTC TV Submission?

Please visit DDMAC’s submission page for information on what constitutes a complete and reviewable DTC TV submission, and for information on other submissions.  DDMAC’s submissions web page is available at http://www.fda.gov/cder/ddmac/submissions.htm.

Federal Register Documents Concerning the DTC User Fee Program

  • DTC User Fee Program Will Not be Implemented [HTML] [PDF] (1/16/08)
  • User Fee Program for Advisory Review of Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products; Request for Notification of Participation and Number of Advertisements for Review [HTML] [PDF] (posted 10/25/2007)
  • Federal Register Notice: Establishment of Fiscal Year 2008 User Fee Rates for Advisory Review of Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products. [HTML] [PDF] (12/13/2007)
     Back to DDMAC

PDF requires the free Adobe Acrobat Reader

Date created: October 1, 2007, Last updated: February 21, 2008

horizonal rule